Business Context and Reporting Period
This Form 8-K is a current report filed by Aldeyra Therapeutics, Inc. on June 26, 2014. The filing addresses a corporate event regarding the company's inclusion in a major market index.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance event rather than financial performance data.
Material Changes
On June 26, 2014, the Company announced it expects to join the Russell Microcap Index. This inclusion is scheduled to take effect when Russell Investments reconstitutes its family of U.S. indexes on June 27, 2014.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of risks and contingencies. The document serves solely to disclose the anticipated index inclusion as an "Other Event" under Item 8.01.
Investor Verification Checklist
- Verify the official announcement of Aldeyra Therapeutics, Inc.'s inclusion in the Russell Microcap Index via the attached press release (Exhibit 99.1).
- Confirm the effective date of the index reconstitution by Russell Investments on June 27, 2014.
- Note that the information in this filing is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.